Advanced search
Publication Cover
Libyan Journal of Medicine Volume 18, 2023 - Issue 1
Submit an article Journal homepage
1,520
Views
1
CrossRef citations to date
0
Altmetric
Original Article

MEX3A promotes angiogenesis in colorectal cancer via glycolysis

Yong Lua Department of Gastrointestinal Surgery, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, ChinaView further author information
,
Tienan Bia Department of Gastrointestinal Surgery, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, ChinaView further author information
,
Shenkang Zhoua Department of Gastrointestinal Surgery, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, ChinaView further author information
&
Minhui Guob Department of Gynecology, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, Taizhou, ChinaCorrespondence[email protected]
View further author information
Article: 2202446 | Received 10 Nov 2022, Accepted 10 Apr 2023, Published online: 08 May 2023

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–9.
  • Aguiar Junior S, Oliveira MM, Silva D, et al. Survival of patients with colorectal cancer in a cancer center. Arq Gastroenterol. 2020;57(2):172–177.
  • Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669–685.
  • Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004;350(23):2335–2342.
  • Panzeri V, Manni I, Capone A, et al. The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma. Mol Oncol. 2021;15(2):579–595.
  • Naef V, De Sarlo M, Testa G, et al. The stemness gene Mex3A is a key regulator of neuroblast proliferation during neurogenesis. Front Cell Dev Biol. 2020;8:549533.
  • Zhou X, Li S, Ma T, et al. MEX3A knockdown inhibits the tumorigenesis of colorectal cancer via modulating CDK2 expression. Exp Ther Med. 2021;22(5):1343.
  • Wang B, Hong Z, Zhao C, et al. The effects of MEX3A knockdown on proliferation, apoptosis and migration of osteosarcoma cells. Cancer Cell Int. 2021;21(1):197.
  • Liang J, Li H, Han J, et al. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Cell Death Dis. 2020;11(8):614.
  • Li H, Liang J, Wang J, et al. Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa-miR-6887-3p. Cancer Commun (Lond). 2021;41(6):472–491.
  • Li L, Liang Y, Kang L, et al. Transcriptional regulation of the Warburg effect in cancer by SIX1. Cancer Cell. 2018;33(3):368–385 e7.
  • Shi T, Ma Y, Cao L, et al. B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2. Cell Death Dis. 2019;10(4):308.
  • Shi X, Sun Y, Zhang Y, et al. MEX3A promotes development and progression of breast cancer through regulation of PIK3CA. Exp Cell Res. 2021;404(1):112580.
  • Wang Y, Liang Q, Lei K, et al. Targeting MEX3A attenuates metastasis of breast cancer via beta-catenin signaling pathway inhibition. Cancer Lett. 2021;521:50–63.
  • Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298–307.
  • Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70.
  • Mihalache A, Rogoveanu I. Angiogenesis factors involved in the pathogenesis of colorectal cancer. Curr Health Sci J. 2014;40(1):5–11.
  • Lopez A, Harada K, Vasilakopoulou M, et al. Targeting angiogenesis in colorectal carcinoma. Drugs. 2019;79(1):63–74.
  • Yang C, Zhan H, Zhao Y, et al. MEX3A contributes to development and progression of glioma through regulating cell proliferation and cell migration and targeting CCL2. Cell Death Dis. 2021;12(1):14.
  • Wang X, Shan YQ, Tan QQ, et al. MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma. Cancer Cell Int. 2020;20:63.
  • Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152.
  • Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 2013;123(9):3685–3692.
  • Deng X, Li D, Ke X, et al. Mir-488 alleviates chemoresistance and glycolysis of colorectal cancer by targeting PFKFB3. J Clin Lab Anal. 2021;35(1):e23578.
  • Ren J, Li W, Pan G, et al. MiR-142-3p modulates cell invasion and migration via PKM2-mediated aerobic glycolysis in colorectal cancer. Anal Cell Pathol (Amst). 2021;2021:9927720.
  • Deng F, Zhou R, Lin C, et al. Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer. Theranostics. 2019;9(4):1001–1014.
  • Yang JG, Wang WM, Xia HF, et al. Lymphotoxin-alpha promotes tumor angiogenesis in HNSCC by modulating glycolysis in a PFKFB3-dependent manner. Int J Cancer. 2019;145(5):1358–1370.
  • Wade SM, Ohnesorge N, McLoughlin H, et al. Dysregulated miR-125a promotes angiogenesis through enhanced glycolysis. EBioMedicine. 2019;47:402–413.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.